<法規>
<法規性質>命令</法規性質>
<英文法規名稱>Regulations Governing Management of Infectious Biological Materials</英文法規名稱>
<中文法規名稱>感染性生物材料管理辦法</中文法規名稱>
<法規網址>http://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE=L0050029</法規網址>
<最新英文異動日期>20140311</最新英文異動日期>
<廢止註記>
</廢止註記>
<沿革內容><![CDATA[1. Formulated and announced in 19 articles by the Department of Health, the Executive Yuan, on September 26, 2005, under Shu-Shou-Chi Order No. 0940000614; and implemented as of March 26, 2006.
2. Amended and announced Article 2-1 and Article 19 on April 11, 2006, by the Department of Health, the Executive Yuan, under Shu-Shou-Chi Order No. 0950000194
3. Amended the title (original title: Regulations Governing Management of Infectious Biological Materials and Collection of Specimens from Patients of Communicable Diseases) and 21 articles, and announced by the Ministry of Health and Welfare on March 11, 2014 under Bu-Shou-Chi Order No. 1030100208]]></沿革內容>
<法規內容>
  <條文>
    <條號>Article 1</條號>
    <條文內容><![CDATA[This set of Regulations is formulated in accordance with regulations of Paragraph 3, Article 34 of the Communicable Disease Control Act (hereafter referred to as the Act).
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2</條號>
    <條文內容><![CDATA[The established unit referred to in this set of Regulations means an organization (institution), group or enterprise that keeps, stores, uses, disposes, exports and imports infectious biological materials and has set up a laboratory or storage unit for the safekeeping of biological materials.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 3</條號>
    <條文內容><![CDATA[The pathogens referred to in Paragraph 4 of Article 4 of the Act, by their hazardous risks of pathogenicity, are classified into four risk groups of microorganisms:
1. Risk Group 1: refers to microorganisms such as Escherichia coli K-12, Adeno-associated virus types 1 through 4 and others that do not impact on human health;
2. Risk Group 2: refers to microorganisms such as Staphylococcus aureus, hepatitis B virus, Plasmodium falciparum and others that impact on human health moderately, and for them, there are usually preventive measures and cure available;
3. Risk Group 3: refers to microorganisms such as Mycobacterium tuberculosis, Human Immunodeficiency Virus Type 1 and Type 2 and others that impact on human health severely and may even be fatal, and for them, there may be preventive measures and cure;
4. Risk Group 4: refers to microorganisms such as Ebola virus, Variola (major and minor) virus and others that impact on human health severely and may even be fatal, and for them, there are usually no preventive measures and cure available.
Directions concerning the classification, items and packing of the above-mentioned risk group microorganisms shall be decided separately by the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 4</條號>
    <條文內容><![CDATA[In the event that the derivatives of pathogens mentioned in Paragraph 4, Article 4 of the Act are biotoxins, they refer to biotoxins such as Cholera toxin and Botulinum neurotoxins; they are classified, by their possible use as biological agents, into general and select biotoxins.
Directions concerning the classification, items, total quantity of control of the biotoxins mentioned in the preceding Paragraph shall be decided separately by the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 5</條號>
    <條文內容><![CDATA[Laboratories using infectious biological materials (hereafter referred to as the laboratory) , by their operational practices, personnel protective equipment, safety equipment and facilities, are classified into four biosafety levels.
The operational practices of the laboratory of various biosafety levels referred to in the preceding Paragraph, including the operational practices concerning their personnel protective equipment, safety equipments and facilities, shall be decided separately by the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 6</條號>
    <條文內容><![CDATA[For the management of Risk Group 2 and above microorganisms or biotoxins, the established units shall set up a biosafety committee (referred to hereafter as the committee); if the number of employees does not exceed five persons, a person who is responsible for biosafety matters (hereafter referred to as the biosafety staff) may be assigned in its place.
Members of the committee are as follows:
1. Director or deputy director of the established units,
2. Chief of laboratory or safekeeping place,
3. Management personnel, engineering personnel of the laboratory or safekeeping place, or other personnel with relevant professional knowledge.
The biosafety staff shall possess relevant professional knowledge and a minimum of 16 hours of training in biosafety, and a minimum of three years of experience in laboratories.
The established units must, within one month after the establishment of the biosafety committee or the assignment of the biosafety staff, report to the central competent authority for reference, copy to local competent authority. The same applies to any changes.
The established units shall have adequate management mechanisms over Risk Group 1 microorganisms or non biotoxin derivatives and Biosafety level 1 laboratories.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 7</條號>
    <條文內容><![CDATA[Duties of the biosafety committee and the biosafety staff are as follows:
1. Review the safe keeping, storage, use, disposal, or import and export of Risk Group 2 and above microorganisms or biotoxins;
2. Review the Biosafety level of laboratories using Risk Group 2 and above microorganisms or biotoxins;
3. Review the biosafety emergency response plans of laboratories;
4. Review the plans of building, reconstruction, extension, inception and termination of use of the laboratories;
5. Review matters concerning disputes about biosafety of laboratories;
6. Supervise the annual internal auditing and defect improvement of the biosafety of laboratories;
7. Supervise the biosafety training of laboratory personnel;
8. Review and supervise other matters concerning management of infectious biological materials and biosafety of laboratories;
9. Handle, investigate and report biosafety accidents of laboratories.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 8</條號>
    <條文內容><![CDATA[Laboratories may keep, stroe or dispose Risk Group 2 and above microorganisms or biotoxins only after passing the inspection conducted by the biosafety committee or the biosafety staff.
Laboratories may keep, store, or dispose Risk Group 3 and above microorganisms or select biotoxins by regulations of the preceding Paragraph; in addition, the established units shall report to the central competent authority for permission.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 9</條號>
    <條文內容><![CDATA[Laboratories shall periodically make an inventory of the items and quantity of the Risk Group 2 and above microorganisms or biotoxins in their safe keeping and storage. If abnormal incidents such as shortage or loss are detected, the matter shall be reported immediately to the biosafety committee or the biosafety staff.
The established units shall, within 24 hours, report to the competent authority any abnormal events of Risk Group 3 and above microorganisms or select biotoxins when detected.
The biosafety committee or the biosafety staff shall complete investigation of the abnormal event within seven days from the next day the report is received; the established units shall, within three days from the next day the investigation is completed, submit the investigation report to the local competent authority for reference, copy to the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 10</條號>
    <條文內容><![CDATA[Biosafety accidents of laboratories, by the degree of leakage of the infectious biological materials, can be classified into high, moderate, and low levels:
1. High level: the infectious biological materials have leaked to areas outside the laboratory, and have the fear of infecting or harming laboratory personnel, personnel of other departments, or community people in the neighborhood.
2. Moderate level: leakage of infectious biological materials is confined within the laboratory area, and may have the fear of infecting or harming laboratory personnel.
3. Low level: leakage of infectious biological materials is limited within the safety equipment of the laboratory, and may have less fear of infecting or harming laboratory personnel.
Directions governing the risk levels, explanation, reporting, and management of the biosafety accidents of laboratories mentioned in the preceding Paragraph shall be decided separately by the central competent authority.
The established units shall ensure that there is no fear of infectious biological materials leaking to cause infections, and set up the following biosafety emergency response plans in accordance with the risk levels, reporting and management of biosafety accidents of laboratories:
1. Emergency response team and tasks,
2. Appraisal of the level of accidents and risk assessment,
3. Warning, management and reporting mechanisms of accidents,
4. Inventory management of the emergency response supplies,
5. Procedures of emergency medical care and rescue,
6. Safety protection measures for response personnel,
7. Evacuation procedures for emergency response and other responsive measures,
8. Cleaning, disinfection, renovation of hazard areas, coordination with other personnel of the organization, rehabilitative measures, and investigation report.
The established units shall, each year by these emergency response plans of the preceding Paragraph, conduct simulated response field drills.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 11</條號>
    <條文內容><![CDATA[The established units shall conduct following matters with the keeping places of Risk Group 2 and above microorganisms or biotoxins:
1. Assign a person on special duty to be responsible for the management,
2. Admission control setting,
3. There are stock inventories and records of retrieval and storage.
When necessary, the competent authority may conduct auditing in coordination with organizations concerned.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 12</條號>
    <條文內容><![CDATA[In the import and export of infectious biological materials, the established units shall, by regulations of Paragraph 2, Article 34 of the Act, submit applications and relevant documents to the central competent authority for permission.
In the event that the infectious biological materials imported or exported are Risk Group 2 and above microorganisms or biotoxins, documentation of consent by the biosafety committee or the biosafety satff shall accompany.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 13</條號>
    <條文內容><![CDATA[For the need of disease control, the central competent authority may order the established units to, within specified time, self-destroy or collectively destroy certain infectious biological materials.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 14</條號>
    <條文內容><![CDATA[In transporting infectious biological materials, the established units shall meet the triple packaging rules that are decided separately by the central competent authority; in the air transportation of infectious biological materials, their packing regulations shall follow those of the competent business authority.
In the event that the infectious biological materials leak in the process of transportation, transportation-related personnel shall promptly undertake necessary measures, and report to the established units that entrusts the transportation. Upon receipt of notice, the established units shall immediately inform the local competent authority of the accidents.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 15</條號>
    <條文內容><![CDATA[The central competent authority may conduct auditing of the established units with laboratories of Biosafety level 3 and above or keeping, using Risk Group 3 and above microorganisms or select biotoxins.
Local competent authority may conduct auditing of established units in their locality with Biosafety level 1, level 2 laboratories, or keeping, using Risk Group 2 microorganisms or general biotoxins; when necessary, the central competent authority may assign person for supervision or auditing.
When defects are found in auditing, the competent authority shall order for improvement in due time.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 16</條號>
    <條文內容><![CDATA[The newly established laboratories of Biosafety level 3 and above may be inaugurated for use after the consent of the biosafety committee of the established units, and submitting for approval to the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 17</條號>
    <條文內容><![CDATA[When biosafety accidents occur or are feared to occur in laboratory of the established units, the competent authority may order the laboratory to suspend the use of relevant infectious biological materials.
When the laboratory safety concern in the preceding Paragraph is properly addressed, which has also been confirmed by the biosafety committee or biosafety staff of the established units, the laboratory may resume operations again after reporting to the competent authority that all safety issues have been addressed for consent of re-operation.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 18</條號>
    <條文內容><![CDATA[Biosafety level 2 and above laboratories shall indicate in distinct place level of biosafety, bio-hazards signs, names of director and person-in-charge, telephone numbers and measures for emergency management.
The established units shall conduct regularly health examination of the laboratory personnel mentioned in the preceding Paragraph and establish monitoring mechanisms for abnormal health conditions.
For personnel of laboratories using Risk Group 3 and above microorganisms, the established units shall safe-keep their serum specimens for ten years after they have left the job. For personnel of laboratories using Risk Group 2 and below microorganisms, their serum specimens and safe-keeping period shall be decided by the biosafety committee.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 19</條號>
    <條文內容><![CDATA[New recruits of laboratories shall accept a minimum of eight hours of training in biosafety of laboratories.
Personnel of laboratories shall undertake each year a minimum of four hours of continuing education in biosafety of laboratories.
New recruits of laboratories of Biosafety level 3 and above shall take part in the biosafety training certified by the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 20</條號>
    <條文內容><![CDATA[The central competent authority may commission or entrust relevant organizations (institutions), juridical persons or groups to conduct matters mentioned in Article 8 through Article 17 and the preceding Article.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 21</條號>
    <條文內容><![CDATA[This set of Regulations shall be implemented on the day of announcement.
]]></條文內容>
  </條文>
</法規內容>
</法規>
